NCT01325194 - CHemoImmunotherapy With Early Central Nervous System (CNS) Prophylaxis | Biotech Hunter

Enrollment

143

Participants

Timeline

Start Date

March 31, 2011

Primary Completion Date

November 30, 2018

Study Completion Date

December 31, 2019

Conditions

Primary Disease

Interventions

DRUG

liposomal cytarabine

50 mg intrathecally three times

Trial Locations (4)

Department of Hematology, Århus University Hospital, Aarhus

Department of Oncology, Helsinki University Central Hospital, Helsinki

Department of Oncology, Oslo University Hospital, Oslo

Department of Oncology, Lund University Hospital, Lund